EuroPCR 2026: Late-Breaking Trials and Hotlines

Cutting-edge evidence that shapes clinical decisions

EuroPCR is where education meets evidence, bringing you the latest breakthroughs in interventional cardiology. This year’s Major Late-Breaking Trials session will unveil three pivotal studies selected from the best submissions, while Hotline sessions will provide essential updates on key clinical trials and registries.

Focus on 3 high-impact presentations ✨

3 Major Late-Breaking Trials that have the potential to make a particularly significant impact on your current practice, were selected from the call for submissions. Save space in your agenda for the dedicated session of the programme showcasing these presentations:

Long-term mortality following PCI with DES vs. CABG for left main disease - Brian Bergmark
Outcomes of LAA closure vs. NOAC in patients with atrial fibrillation across different age groups - Jens Erik Nielsen-Kudsk
Coronary revascularisation in patients undergoing TAVI: an IPD meta-analysis of four randomised trials - Roberto Scarsini

Hotlines: Unveiling Key Clinical Insights

Beyond Late-Breaking Trials, Hotline sessions provide first-hand access to major trial updates, registry results, and follow-up data that shape clinical decision-making. These fast-paced, high-impact presentations deliver the latest findings from the most relevant studies in interventional cardiology.

Stay up to date with the evidence that matters

Browse sessions and presentations below ⬇️